Safety, Tolerability, and Pharmacokinetics of BGB-23339 in Healthy Japanese and Caucasian Subjects

⟵ Back to Search Results

Beigene Study ID

BGB-23339-102

ClinicalTrials.gov ID

NCT05387668

Sex: All

Age: 18 Years to 55 Years (Adult)

No Study Documents

Locations

Sex: All

Age: 18 Years to 55 Years (Adult)

No Study Documents